<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">32192466</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>12</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>12</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1471-2474</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>21</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Mar</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>BMC musculoskeletal disorders</Title>
          <ISOAbbreviation>BMC Musculoskelet Disord</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Determining the association between fibromyalgia, the gut microbiome and its biomarkers: A systematic review.</ArticleTitle>
        <Pagination>
          <StartPage>181</StartPage>
          <MedlinePgn>181</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">181</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12891-020-03201-9</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The association between fibromyalgia and irritable bowel syndrome is well-established. Alterations in the composition and diversity of the gut microbiome in irritable bowel syndrome have been reported, however, this association is poorly understood in fibromyalgia. Our aim was to summarise the research reporting on the gastrointestinal microbiome and its biomarkers in people with fibromyalgia.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">A systematic review of published original research reporting on the gastrointestinal microbiota and its biomarkers in adults with a diagnosis of fibromyalgia was undertaken.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">From 4771 studies, 11 met our inclusion criteria and were separated into four main groups: papers reporting Helicobacter pylori; other gut bacterial markers; metabolomics and other biomarkers, which included intestinal permeability and small intestinal bacterial overgrowth.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results suggest there is a paucity of quality research in this area, with indications that the gut microbiota may play a role in fibromyalgia within the emerging field of the gut-musculoskeletal axis. Further investigations into the relationship between the gut microbiota, gut dysfunction and fibromyalgia are warranted.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Erdrich</LastName>
            <ForeName>Sharon</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0002-8448-5644</Identifier>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, New South Wales, Australia. Sharon.erdrich@sydney.edu.au.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hawrelak</LastName>
            <ForeName>Jason A</ForeName>
            <Initials>JA</Initials>
            <AffiliationInfo>
              <Affiliation>College of Health and Medicine, University of Tasmania, Hobart, Tasmania, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Myers</LastName>
            <ForeName>Stephen P</ForeName>
            <Initials>SP</Initials>
            <AffiliationInfo>
              <Affiliation>NatMed Research Unit, Division of Research, Southern Cross University, Lismore, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Harnett</LastName>
            <ForeName>Joanna E</ForeName>
            <Initials>JE</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, New South Wales, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D000078182">Systematic Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>03</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>BMC Musculoskelet Disord</MedlineTA>
        <NlmUniqueID>100968565</NlmUniqueID>
        <ISSNLinking>1471-2474</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005356" MajorTopicYN="N">Fibromyalgia</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055432" MajorTopicYN="N">Metabolomics</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Biomarkers</Keyword>
        <Keyword MajorTopicYN="N">Fibromyalgia</Keyword>
        <Keyword MajorTopicYN="N">Fibromyalgia syndrome</Keyword>
        <Keyword MajorTopicYN="N">Gastrointestinal microbiome</Keyword>
        <Keyword MajorTopicYN="N">Systematic review</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32192466</ArticleId>
        <ArticleId IdType="pmc">PMC7083062</ArticleId>
        <ArticleId IdType="doi">10.1186/s12891-020-03201-9</ArticleId>
        <ArticleId IdType="pii">10.1186/s12891-020-03201-9</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Inanici F, Yunus MB. History of fibromyalgia: past to present. Curr Pain Headache Rep. 2004;8(5):369–378. doi: 10.1007/s11916-996-0010-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11916-996-0010-6</ArticleId>
            <ArticleId IdType="pubmed">15361321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Macfarlane G J, Kronisch C, Dean L E, Atzeni F, Häuser W, Fluß E, Choy E, Kosek E, Amris K, Branco J, Dincer F, Leino-Arjas P, Longley K, McCarthy G M, Makri S, Perrot S, Sarzi-Puttini P, Taylor A, Jones G T. EULAR revised recommendations for the management of fibromyalgia. Annals of the Rheumatic Diseases. 2016;76(2):318–328. doi: 10.1136/annrheumdis-2016-209724.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2016-209724</ArticleId>
            <ArticleId IdType="pubmed">27377815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marques AP, AdSdE S, Berssaneti AA, Matsutani LA, SLK Y. Prevalence of fibromyalgia: Literature review update. Rev Bras Reumatol Eng Ed. 2017;57(4):356–363. doi: 10.1016/j.rbr.2016.10.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rbr.2016.10.004</ArticleId>
            <ArticleId IdType="pubmed">28743363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lacasse A, Bourgault P, Choinière M. Fibromyalgia-related costs and loss of productivity: a substantial societal burden. BMC Musculoskelet Disord. 2016;17:168. doi: 10.1186/s12891-016-1027-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12891-016-1027-6</ArticleId>
            <ArticleId IdType="pmc">PMC4833946</ArticleId>
            <ArticleId IdType="pubmed">27084363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arnold LM, Bennett RM, Crofford LJ, Dean LE, Clauw DJ, Goldenberg DL, Fitzcharles M-A, Paiva ES, Staud R, Sarzi-Puttini P, et al.  AAPT diagnostic criteria for fibromyalgia. J Pain. 2019;20(6):611–628. doi: 10.1016/j.jpain.2018.10.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpain.2018.10.008</ArticleId>
            <ArticleId IdType="pubmed">30453109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cassisi G, Sarzi-Puttini P, Cazzola M. Chronic widespread pain and fibromyalgia: Could there be some relationship with infections and vaccinations? Clin Exp Rheumatol. 2011;29(6 Suppl. 69):S118–S126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22243559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Becker S, Schweinhardt P. Dysfunctional neurotransmitter systems in fibromyalgia, their role in central stress circuitry and pharmacological actions on these systems. Pain Res Treat. 2012;2012. Article ID:741746.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3195783</ArticleId>
            <ArticleId IdType="pubmed">22110944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Albrecht DS, Forsberg A, Sandstrom A, Bergan C, Kadetoff D, Protsenko E, Lampa J, Lee YC, Hoglund CO, Catana C, et al.  Brain glial activation in fibromyalgia - a multi-site positron emission tomography investigation. Brain Behav Immun. 2019;75:72–83. doi: 10.1016/j.bbi.2018.09.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbi.2018.09.018</ArticleId>
            <ArticleId IdType="pmc">PMC6541932</ArticleId>
            <ArticleId IdType="pubmed">30223011</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grayston R, Czanner G, Elhadd K, Goebel A, Frank B, Üçeyler N, Malik RA, Alam U. A systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia: implications for a new paradigm in fibromyalgia etiopathogenesis. Semin Arthritis Rheum. 2019;48(5):933–940. doi: 10.1016/j.semarthrit.2018.08.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semarthrit.2018.08.003</ArticleId>
            <ArticleId IdType="pubmed">30314675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giacomelli C, Sernissi F, Rossi A, Bombardieri S, Bazzichi L. Biomarkers in fibromyalgia: A review. Curr Biomarker Find. 2014;4:35–41. doi: 10.2147/CBF.S38161.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/CBF.S38161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Erdrich S, Hawrelak J, Myers S, Harnett J.  A systematic review of the association between fibromyalgia and functional gastrointestinal disorders (FGID) 2020. </Citation>
        </Reference>
        <Reference>
          <Citation>Casén C, Vebø HC, Sekelja M, Hegge FT, Karlsson MK, Ciemniejewska E, Dzankovic S, Frøyland C, Nestestog R, Engstrand L, et al.  Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD. Aliment Pharmacol Ther. 2015;42(1):71–83. doi: 10.1111/apt.13236.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/apt.13236</ArticleId>
            <ArticleId IdType="pmc">PMC5029765</ArticleId>
            <ArticleId IdType="pubmed">25973666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sperber AD, Atzmon Y, Neumann L, Weisberg I, Shalit Y, Abu-Shakrah M, Fich A, Buskila D. Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Am J Gastroenterol. 1999;94(12):3541–3546. doi: 10.1111/j.1572-0241.1999.01643.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1572-0241.1999.01643.x</ArticleId>
            <ArticleId IdType="pubmed">10606316</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology. 2002;122(4):1140–1156. doi: 10.1053/gast.2002.32392.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/gast.2002.32392</ArticleId>
            <ArticleId IdType="pubmed">11910364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moher D, Liberati A, Tetzlaff J, Altman DG, The PG  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi: 10.1371/journal.pmed.1000097.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pmed.1000097</ArticleId>
            <ArticleId IdType="pmc">PMC2707599</ArticleId>
            <ArticleId IdType="pubmed">19621072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi RPM, Lisy K, et al. Systematic reviews of etiology and risk In: Aromataris E, Munn Z, editors. Joanna Briggs Institute Reviewer's Manual. Adelaide: The Joanna Briggs Institute; 2017. Available from https://reviewersmanual.joannabriggs.org/.</Citation>
        </Reference>
        <Reference>
          <Citation>Pimentel M, Wallace D, Hallegua D, Chow E, Kong Y, Park S, Lin HC. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis. 2004;63:450–452. doi: 10.1136/ard.2003.011502.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/ard.2003.011502</ArticleId>
            <ArticleId IdType="pmc">PMC1754959</ArticleId>
            <ArticleId IdType="pubmed">15020342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michalsen A, Riegert M, Ludtke R, Backer M, Langhorst J, Schwickert M, Dobos GJ. Mediterranean diet or extented fasting's influence on changing the intestinal microflora, immunoglobulin A secretion and clinical outcome in patients with rheumatiod arthritis and fibromyalgia: An observational study. BMC Complement Altern Med. 2005;5(22). 10.1186/1472-6882-5-22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1352378</ArticleId>
            <ArticleId IdType="pubmed">16372904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goebel A, Buhner S, Schedel R, Lochs H, Sprotte G. Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome. Rheumatology. 2008;47(8):1223–1227. doi: 10.1093/rheumatology/ken140.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/rheumatology/ken140</ArticleId>
            <ArticleId IdType="pubmed">18540025</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Akkaya N, Akkaya S, Polat Y, Turk M, Turk T, Turhal E, Sahin F. Helicobacter pylori seropositivity in fibromyalgia syndrome. Clin Rheumatol. 2011;30(1):43–49. doi: 10.1007/s10067-010-1618-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10067-010-1618-9</ArticleId>
            <ArticleId IdType="pubmed">21120564</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olama SM, El-Arman M. Helicobacter pylori in Egyptian patients with fibromyalgia syndrome. Egypt Rheumatologist. 2013;35(3):167–173. doi: 10.1016/j.ejr.2013.01.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejr.2013.01.004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodrigo L, Blanco I, Bobes J, de Serres FJ. Remarkable prevalence of coeliac disease in patients with irritable bowel syndrome plus fibromyalgia in comparison with those with isolated irritable bowel syndrome: a case-finding study. Arthritis Res Ther. 2013;15:R201. doi: 10.1186/ar4391.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/ar4391</ArticleId>
            <ArticleId IdType="pmc">PMC3978893</ArticleId>
            <ArticleId IdType="pubmed">24283458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gezici E, Alpayci M, Ozkan Y, Kucuk ME, Unver H, Hiz O. The effects of helicobacter pylori eradication on the number of tender points, sleep quality, depression, and anxiety in patients with fibromyalgia. Arch Rheumatol. 2014;29(3):151–154. doi: 10.5606/ArchRheumatol.2014.3983.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5606/ArchRheumatol.2014.3983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malatji BG, Meyer H, Mason S, Engelke UFH, Wevers RA, van Reenen M, Reinecke CJ. A diagnostic biomarker profile for fibromyalgia syndrome based on an NMR metabolomics study of selected patients and controls. BMC Neurol. 2017;17:88. doi: 10.1186/s12883-017-0863-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12883-017-0863-9</ArticleId>
            <ArticleId IdType="pmc">PMC5426044</ArticleId>
            <ArticleId IdType="pubmed">28490352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Malatji BG, Mason S, Mienie LJ, Wevers RA, Meyer H, van Reenen M, Reinecke CJ. The GC-MS metabolomics signature in patients with fibromyalgia syndrome directs to dysbiosis as an aspect contributing factor of FMS pathophysiology. Metabolomics. 2019;15:54. doi: 10.1007/s11306-019-1513-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11306-019-1513-6</ArticleId>
            <ArticleId IdType="pubmed">30919098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clos-Garcia M, Andres-Marin N, Fernandez-Eulate G, Abecia L, Lavin JL, van Liempd S, Cabrera D, Royo F, Valero A, Errazquin N, et al.  Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia. EBioMedicine. 2019;46:499–511. doi: 10.1016/j.ebiom.2019.07.031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ebiom.2019.07.031</ArticleId>
            <ArticleId IdType="pmc">PMC6710987</ArticleId>
            <ArticleId IdType="pubmed">31327695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Minerbi A, Gonzalez E, Brereton NJB, Anjarkouchian A, Dewar K, Fitzcharles MA, Chevalier S, Shir Y. Altered microbiome composition in individuals with fibromyalgia. Pain. 2019;00:1–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31219947</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kayali S, Aloe R, Bonaguri C, Gaiani F, Manfredi M, Leandro G, Fornaroli F, Di Mario F. De' Angelis GL: non-invasive tests for the diagnosis of helicobacter pylori: state of the art. Acta Biomed. 2018;89(Suppl 8):58–64.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6502209</ArticleId>
            <ArticleId IdType="pubmed">30561419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McKenna T, Mohabbat A, Salonen B, Raslau D, Luedtke C. Prevalence of celiac disease in fibromyalgia patients: The Mayo Clinic experience. J Gen Intern Med. 2017;32(2 Suppl. 1):S287.</Citation>
        </Reference>
        <Reference>
          <Citation>Antonova V, Kopishinskaya S, Gustov A, Repin A. Fibromyalgia in celiac disease patients. Eur J Neurol. 2012;19(Suppl.1):628.</Citation>
        </Reference>
        <Reference>
          <Citation>Talley NJ, Walker MM. Celiac disease and nonceliac gluten or wheat sensitivity: the risks and benefits of diagnosis. JAMA Intern Med. 2017;177(5):615–616. doi: 10.1001/jamainternmed.2017.0695.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamainternmed.2017.0695</ArticleId>
            <ArticleId IdType="pubmed">28350893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brown I, Mino-Kenudson M, Deshpande V, Lauwers GY. Intraepithelial lymphocytosis in architecturally preserved proximal small intestinal mucosa: an increasing diagnostic problem with a wide differential diagnosis. Arch Pathol Lab Med. 2006;130(7):1020–1025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16831028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simondi D, Ribaldone DG, Bonagura GA, Foi S, Sapone N, Garavagno M, Villanacci V, Bernardi D, Pellicano R, Rizzetto M, et al.  Helicobacter pylori in celiac disease and in duodenal intraepithelial lymphocytosis: active protagonist or innocent bystander? Clin Res Hepatol Gastroenterol. 2015;39(6):740–745. doi: 10.1016/j.clinre.2015.03.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clinre.2015.03.005</ArticleId>
            <ArticleId IdType="pubmed">25956489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ozaydin N, Turkyilmaz SA, Cali S. Prevalence and risk factors of helicobacter pylori in Turkey: a nationally-representative, cross-sectional, screening with the 13C-urea breath test. BMC Public Health. 2013;13:1215. doi: 10.1186/1471-2458-13-1215.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2458-13-1215</ArticleId>
            <ArticleId IdType="pmc">PMC3880349</ArticleId>
            <ArticleId IdType="pubmed">24359515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng W-P, Wang Z-Q, Deng J-Q, Liu Y, Deng M-M, Lü M-H. The role of H. pylori CagA in regulating hormones of functional dyspepsia patients. Gastroenterol Res Pract, Article ID. 2016:7150959.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5093276</ArticleId>
            <ArticleId IdType="pubmed">27840636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gist AC, Guymer EK, Eades LE, Leech M, Littlejohn GO. Fibromyalgia remains a significant burden in rheumatoid arthritis patients in Australia. Int J Rheum Dis. 2018;21(3):639–646. doi: 10.1111/1756-185X.13055.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/1756-185X.13055</ArticleId>
            <ArticleId IdType="pubmed">28296177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zautner AE, Johann C, Strubel A, Busse C, Tareen AM, Masanta WO, Lugert R, Schmidt-Ott R, Groß U. Seroprevalence of campylobacteriosis and relevant post-infectious sequelae. Eur J Clin Microbiol Infect Dis. 2014;33(6):1019–1027. doi: 10.1007/s10096-013-2040-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-013-2040-4</ArticleId>
            <ArticleId IdType="pmc">PMC4013439</ArticleId>
            <ArticleId IdType="pubmed">24413899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cohen D, Shoham O, Orr N, Muhsen K. An inverse and independent association between helicobacter pylori infection and the incidence of shigellosis and other diarrheal diseases. Clin Infect Dis. 2012;54(4):e35–e42. doi: 10.1093/cid/cir916.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cir916</ArticleId>
            <ArticleId IdType="pubmed">22157171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kovats RS, Edwards SJ, Charron D, Cowden J, D'Souza RM, Ebi KL, Gauci C, Gerner-Smidt P, Hajat S, Hales S, et al.  Climate variability and campylobacter infection: an international study. Int J Biometeorol. 2005;49(4):207–214. doi: 10.1007/s00484-004-0241-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00484-004-0241-3</ArticleId>
            <ArticleId IdType="pubmed">15565278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olson CA, Vuong HE, Yano JM, Liang QY, Nusbaum DJ, Hsiao EY. The gut microbiota mediates the anti-seizure effects of the ketogenic diet. Cell. 2018;173:1728–1741. doi: 10.1016/j.cell.2018.04.027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2018.04.027</ArticleId>
            <ArticleId IdType="pmc">PMC6003870</ArticleId>
            <ArticleId IdType="pubmed">29804833</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pyke LT, Osmotherly GP, Baines GS. Measuring glutamate levels in the brains of fibromyalgia patients and a potential role for glutamate in the pathophysiology of fibromyalgia symptoms: a systematic review. Clin J Pain. 2017;33(10):944–954. doi: 10.1097/AJP.0000000000000474.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/AJP.0000000000000474</ArticleId>
            <ArticleId IdType="pubmed">28033157</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baj A, Moro E, Bistoletti M, Orlandi V, Crema F, Giaroni C. Glutamatergic signaling along the microbiota-gut-brain axis. Int J Mol Sci. 2019;20(6):1482. doi: 10.3390/ijms20061482.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms20061482</ArticleId>
            <ArticleId IdType="pmc">PMC6471396</ArticleId>
            <ArticleId IdType="pubmed">30934533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harris RE, Sundgren PC, Craig AD, Kirshenbaum E, Sen A, Napadow V, Clauw DJ. Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis Rheum. 2009;60(10):3146–3152. doi: 10.1002/art.24849.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.24849</ArticleId>
            <ArticleId IdType="pmc">PMC2827610</ArticleId>
            <ArticleId IdType="pubmed">19790053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gerdle B, Ernberg M, Mannerkorpi K, Larsson B, Kosek E, Christidis N, Ghafouri B. Increased interstitial concentrations of glutamate and pyruvate in vastus lateralis of women with fibromyalgia syndrome are normalized after an exercise intervention - A case-control study. PLoS ONE. 2016;11(10):e0162010. doi: 10.1371/journal.pone.0162010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0162010</ArticleId>
            <ArticleId IdType="pmc">PMC5047648</ArticleId>
            <ArticleId IdType="pubmed">27695113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zunhammer M, Schweizer LM, Witte V, Harris RE, Bingel U, Schmidt-Wilcke T. Combined glutamate and glutamine levels in pain-processing brain regions are associated with individual pain sensitivity. Pain. 2016;157(10):2248–2256. doi: 10.1097/j.pain.0000000000000634.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/j.pain.0000000000000634</ArticleId>
            <ArticleId IdType="pubmed">27649042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foerster BR, Petrou M, Edden RAE, Sundgren PC, Schmidt-Wilcke T, Lowe SE, Harte SE, Clauw DJ, Harris RE. Reduced insular gamma-aminobutyric acid in fibromyalgia. Arthritis Rheum. 2012;64(2):579–583. doi: 10.1002/art.33339.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.33339</ArticleId>
            <ArticleId IdType="pmc">PMC3374930</ArticleId>
            <ArticleId IdType="pubmed">21913179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valdes M, Collado A, Bargallo N, Vazquez M, Rami L, Gomez E, Salamero M. Increased glutamate/glutamine compounds in the brains of patients with fibromyalgia: a magnetic resonance spectroscopy study. Arthritis Rheum. 2010;62(6):1829–1836. doi: 10.1002/art.27430.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.27430</ArticleId>
            <ArticleId IdType="pubmed">20191578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee SH, Yun Y, Kim SJ, Lee E-J, Chang Y, Ryu S, Shin H, Kim H-L, Kim H-N, Lee JH. Association between cigarette smoking status and composition of gut microbiota: population-based cross-sectional study. J Clin Med. 2018;7:282. doi: 10.3390/jcm7090282.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jcm7090282</ArticleId>
            <ArticleId IdType="pmc">PMC6162563</ArticleId>
            <ArticleId IdType="pubmed">30223529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lukić I, Getselter D, Ziv O, Oron O, Reuveni E, Koren O, Elliott E. Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior. Transl Psychiatry. 2019;9:133. doi: 10.1038/s41398-019-0466-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41398-019-0466-x</ArticleId>
            <ArticleId IdType="pmc">PMC6456569</ArticleId>
            <ArticleId IdType="pubmed">30967529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cussotto S, Clarke G, Dinan TG, Cryan JF. Psychotropics and the microbiome: a chamber of secrets. Psychopharmacology. 2019;236(5):1411–1432. doi: 10.1007/s00213-019-5185-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00213-019-5185-8</ArticleId>
            <ArticleId IdType="pmc">PMC6598948</ArticleId>
            <ArticleId IdType="pubmed">30806744</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pozuelo M, Panda S, Santiago A, Mendez S, Accarino A, Santos J, Guarner F, Azpiroz F, Manichanh C. Reduction of butyrate- and methane-producing microorganisms in patients with irritable bowel syndrome. Sci Rep. 2015;5:12693. doi: 10.1038/srep12693.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep12693</ArticleId>
            <ArticleId IdType="pmc">PMC4523847</ArticleId>
            <ArticleId IdType="pubmed">26239401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol. 2011;17(12):1519–1528. doi: 10.3748/wjg.v17.i12.1519.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v17.i12.1519</ArticleId>
            <ArticleId IdType="pmc">PMC3070119</ArticleId>
            <ArticleId IdType="pubmed">21472114</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gerdle B, Soderberg K, Salvador Puigvert L, Rosendal L, Larsson B. Increased interstitial concentrations of pyruvate and lactate in the trapezius muscle of patients with fibromyalgia: a microdialysis study. J Rehabil Med. 2010;42(7):679–687. doi: 10.2340/16501977-0581.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2340/16501977-0581</ArticleId>
            <ArticleId IdType="pubmed">20603699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scheijen JLJM, Hanssen NMJ, van de Waarenburg MPH, Jonkers DMAE, Stehouwer CDA. Schalkwijk CG: L(+) and D(−) lactate are increased in plasma and urine samples of type 2 diabetes as measured by a simultaneous quantification of L(+) and D(−) lactate by reversed-phase liquid chromatography tandem mass spectrometry. Exp Diabetes Res. 2012, Article ID:234812.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3310144</ArticleId>
            <ArticleId IdType="pubmed">22474418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rao SSC, Yu S. Response to Sachdeva et al: brain fogginess and SIBO is not a mirage. Clin Transl Gastroenterol. 2018;9:e194. doi: 10.1038/s41424-018-0061-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41424-018-0061-0</ArticleId>
            <ArticleId IdType="pmc">PMC6173778</ArticleId>
            <ArticleId IdType="pubmed">30291226</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McAllister SJ, Toussaint LL, Williams DA, Hoskin TL, Whipple MO, Vincent A. Perceived dyscognition reported by patients with fibromyalgia. Clin Exp Rheumatol. 2016;34(2):S48–S54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26941074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Connors J, Dawe N, Van Limbergen J. The role of succinate in the regulation of intestinal inflammation. Nutrients. 2018;11(1):25. doi: 10.3390/nu11010025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/nu11010025</ArticleId>
            <ArticleId IdType="pmc">PMC6356305</ArticleId>
            <ArticleId IdType="pubmed">30583500</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sigthorsson G, Tibble J, Hayllar J, Menzies I, Macpherson A, Moots R, Scott D, Gumpel MJ, Bjarnason I. Intestinal permeability and inflammation in patients on NSAIDs. Gut. 1998;43:506–511. doi: 10.1136/gut.43.4.506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gut.43.4.506</ArticleId>
            <ArticleId IdType="pmc">PMC1727292</ArticleId>
            <ArticleId IdType="pubmed">9824578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lambert GP, Schmidt A, Schwarzkopf K, Lanspa S. Effect of aspirin dose on gastrointestinal permeability. Int J Sports Med. 2012;33(6):421–425. doi: 10.1055/s-0032-1301892.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0032-1301892</ArticleId>
            <ArticleId IdType="pubmed">22377941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Camilleri M, Nadeau A, Lamsam J, Linker Nord S, Ryks M, Burton D, Sweetser S, Zinsmeister AR, Singh R. Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion. Neurogastroenterol Motil. 2010;22(1):e15–e26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2802677</ArticleId>
            <ArticleId IdType="pubmed">19614866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leech B, Schloss J, Steel A. Association between increased intestinal permeability and disease: a systematic review. Adv Integr Med. 2018;6:23–34. doi: 10.1016/j.aimed.2018.08.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.aimed.2018.08.003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut. 2019;68:1516–1526. doi: 10.1136/gutjnl-2019-318427.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gutjnl-2019-318427</ArticleId>
            <ArticleId IdType="pmc">PMC6790068</ArticleId>
            <ArticleId IdType="pubmed">31076401</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lauritano EC, Valenza V, Sparano L, Scarpellini E, Gabrielli M, Cazzato A, Ferraro PM, Gasbarrini A. Small intestinal bacterial overgrowth and intestinal permeability. Scand J Gastroenterol. 2010;45(9):1131–1132. doi: 10.3109/00365521.2010.485325.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/00365521.2010.485325</ArticleId>
            <ArticleId IdType="pubmed">20443749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park JH, Park DI, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI, Won KH, Park SM. The relationship between small-intestinal bacterial overgrowth and intestinal permeability in patients with irritable bowel syndrome. Gut Liver. 2009;3(3):174–179. doi: 10.5009/gnl.2009.3.3.174.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5009/gnl.2009.3.3.174</ArticleId>
            <ArticleId IdType="pmc">PMC2852716</ArticleId>
            <ArticleId IdType="pubmed">20431742</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fukuda Y, Bamba H, Okui M, Tamura K, Tanida N, Satomi M, Shimoyama T, Nishigami T. Helicobacter pylori infection increases mucosal permeability of the stomach and intestine. Digestion. 2001;63(Suppl. 1):93–96. doi: 10.1159/000051918.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000051918</ArticleId>
            <ArticleId IdType="pubmed">11173917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Serena C, Ceperuelo-Mallafré V, Keiran N, Queipo-Ortuño MI, Bernal R, Gomez-Huelgas R, Urpi-Sarda M, Ma S, Pérez-Brocal V, Andrés-Lacueva C, et al.  Elevated circulating levels of succinate in human obesity are linked to specific gut microbiota. ISME J. 2018;12:1642–1657. doi: 10.1038/s41396-018-0068-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41396-018-0068-2</ArticleId>
            <ArticleId IdType="pmc">PMC6018807</ArticleId>
            <ArticleId IdType="pubmed">29434314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu D, Cheeseman F, Vanner S. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut. 2011;60(3):334–340. doi: 10.1136/gut.2009.205476.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gut.2009.205476</ArticleId>
            <ArticleId IdType="pubmed">21112950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rezaie A, Buresi M, Lembo A, Lin H, McCallum R, Rao S, Schmulson M, Valdovinos M, Zakko S, Pimentel M. Hydrogen and methane-based breath testing in gastrointestinal disorders: the north American consensus. Am J Gastroenterol. 2017;112(5):775–784. doi: 10.1038/ajg.2017.46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ajg.2017.46</ArticleId>
            <ArticleId IdType="pmc">PMC5418558</ArticleId>
            <ArticleId IdType="pubmed">28323273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pimentel M, Chow EJ, Hallegua D, Wallace D, Lin HC. Small intestinal bacterial overgrowth: a possible association with fibromyalgia. J Musculoskelet Pain. 2001;9(3):107–113. doi: 10.1300/J094v09n03_10.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1300/J094v09n03_10</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mansız-Kaplan B. AB0905 May chronic constipation-induced chronic inflammation affect the onset and severity of fibromyalgia symptoms? Ann Rheum Dis. 2019;78(Suppl. 2):1919.</Citation>
        </Reference>
        <Reference>
          <Citation>Kunkel D, Basseri RJ, Makhani MD, Chong K, Chang C, Pimentel M. Methane on breath testing is associated with constipation: a systematic review and meta-analysis. Dig Dis Sci. 2011;56(6):1612–1618. doi: 10.1007/s10620-011-1590-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10620-011-1590-5</ArticleId>
            <ArticleId IdType="pubmed">21286935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sharon G, Sampson TR, Geschwind DIH, Mazmanian SK. The central nervous system and the gut microbiome. Cell. 2016;167(4):915–932. doi: 10.1016/j.cell.2016.10.027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2016.10.027</ArticleId>
            <ArticleId IdType="pmc">PMC5127403</ArticleId>
            <ArticleId IdType="pubmed">27814521</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
